Stay updated on Combination Treatments in Advanced Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Combination Treatments in Advanced Gastric Cancer Clinical Trial page.

Latest updates to the Combination Treatments in Advanced Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check45 days agoChange DetectedThe page has been updated to reflect a new study on advanced gastric cancer, specifically focusing on the drug BMS-986205 and Rucaparib, while previous details about Nivolumab and Ipilimumab have been removed.SummaryDifference7%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check60 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Combination Treatments in Advanced Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Treatments in Advanced Gastric Cancer Clinical Trial page.